NCT03755791 · Interventional trial
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
Overall registry status Active not recruiting
Phase 3
Conditions Hepatocellular Carcinoma
Delaware Valley sites
- Exelixis Clinical Site #88 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory